Table 2.
Demographics of the Endoscopy Patients in Cohort B With Prior SARS-CoV-2 Infections
| Patient ID | Sample types | Gender | Age (y) | BMI | D.M. | Hypertension | Immunosuppr. | Clinical signs of COVID-19 | Days since SARS-CoV-2 diagnosis | SARS-CoV-2 detection |
|---|---|---|---|---|---|---|---|---|---|---|
| BDH 154 | I, C, CL | M | 54 | 25.4 | N | N | N | Mild, cough | 13 | Y |
| BDH 155 | C, CL | M | 56 | 23.6 | N | N | N | Loss of taste and smell | 24 | N |
| BDH 156 | I, C, CL | M | 55 | 28.4 | N | N | N | Asymptomatic, close contact | 40 | Y |
| BDH 157 | S, D | M | 44 | 25.3 | N | Y | N | Asymptomatic, close contact | 113 | N |
| BDH 158 | I, C, CL | F | 67 | 30.8 | N | Y | N | Cough, loss of taste and smell | 69 | N |
| BDH 159 | C, CL | F | 59 | 22.0 | N | Y | N | Sore throat | 108 | N |
| BDH 160 | I, C, CL | M | 60 | 27.2 | N | N | N | Asymptomatic, close contact | 151 | Y |
| BDH 161 | I, C, CL | F | 57 | 41.7 | N | N | N | Body aches, chills, headache, rhinorrhrea | 76 | N |
| BDH 162 | S, D | M | 69 | 27.7 | N | N | N | Cough, headache, shortness of breath, heaviness in chest | 104 | N |
| BDH 164 | I, C, CL | F | 22 | 22.0 | N | N | N | Loss of taste and smell | ∼200–250 | N |
| BDH 166 | I, C, CL | M | 50 | 33.8 | N | N | N | Cough, diarrhea, fatigue | 129 | N |
| BDH 167 | I, C, CL | F | 51 | 36.1 | N | N | N | Asymptomatic, close contact | 79 | N |
C, colon; D, duodenum; CL, colon liquid; DM, diabetes mellitus; F, female; I, ileum; Immunosuppr., immunosuppressive therapy; M, male; N, no; S, stomach; Y, yes.